Skip to main content
. 2022 Apr 18;11(4):e1388. doi: 10.1002/cti2.1388

Figure 3.

Figure 3

Impact of an additional 3‐month interval between infection (confirmed seroconversion) and vaccination on vaccine‐induced binding and neutralising antibody titres. Effect estimates on binding (blue squares) and neutralising (red squares) on antibody titres against ten SARS‐CoV‐2 variants including SARS‐CoV‐2 wild‐type (A (WT)) and B.1.1.7 (Alpha), B.1.351 (Beta), B.1.526.1 (New York), B.1.617 (India), B.1.617.1 (Kappa), B.1.617.2 (Delta), B.1.617.3 (India), P.1 (Gamma) and P.2 (Zeta) variants following BNT162b2 and ChAdOx1 nCoV‐19 vaccination. Red squares represent the factor increase in SARS‐CoV‐2 spike IgG, and blue squares represent the factor increase in SARS‐CoV‐2 pseudo‐neutralising antibodies per 3 months’ increase in the interval between infection (as defined by confirmed seroconversion) and vaccination.